Department of Gastroenterology, Veterans Affairs Medical Center, Kansas City, MO, USA.
Am J Med Sci. 2010 Oct;340(4):296-300. doi: 10.1097/MAJ.0b013e3181e7fbf3.
The epidermal growth factor receptor (EGFR) pathway is important to colorectal carcinogenesis. Although EGFR is described to be overexpressed in adenomas, to the authors' knowledge, its relationship with advanced features in adenomas and as a marker for adenoma progression has not been studied.
Initially, 13 polyps (sizes 3 mm-5.5 cm) from a 63-year-old patient were stained for EGFR. Subsequently, a validation group of 95 adenomas from 16 patients were graded semiquantitatively for EGFR staining. Size and villous features of the adenomas were evaluated by 2 independent pathologists and compared with EGFR expression. To be classified as advanced, adenomas needed to be greater than 1 cm and fulfill 1 of the 2 criteria-villous component >20% to 25% or presence of high-grade dysplasia.
In the index case, the large 5.5 cm tubulovillous adenoma had EGFR positivity in all of its neoplastic cells, whereas another 2 cm tubular adenoma with focal villous features had 30% EGFR positivity. All other polyps and normal colonic mucosa were negative for EGFR. In 95 adenomas from 16 additional patients, there was a significant correlation of EGFR positivity with adenoma size ≥1 cm and villous features (all P < 0.001). The odds of EGFR expression in advanced adenomas were 17.3 times higher than nonadvanced adenomas (P < 0.001).
These findings suggest that EGFR overexpression is associated with advanced colorectal adenomas. Further larger studies are needed to explore EGFR expression as a biomarker for adenoma progression.
表皮生长因子受体(EGFR)通路对结直肠发生癌变很重要。尽管 EGFR 在腺瘤中被描述为过度表达,但据作者所知,其与腺瘤中的高级特征以及作为腺瘤进展的标志物之间的关系尚未被研究过。
最初,对一位 63 岁患者的 13 个息肉(大小为 3 毫米至 5.5 厘米)进行了 EGFR 染色。随后,对 16 名患者的 95 个腺瘤进行了 EGFR 染色的半定量分级。两名独立的病理学家评估了腺瘤的大小和绒毛特征,并将其与 EGFR 表达进行了比较。为了将其归类为高级别,腺瘤需要大于 1 厘米并满足以下两个标准之一:绒毛成分>20%至 25%或存在高级别异型增生。
在索引病例中,较大的 5.5 厘米管状绒毛状腺瘤的所有肿瘤细胞均呈 EGFR 阳性,而另一个 2 厘米的管状腺瘤伴有局灶性绒毛状特征,其 EGFR 阳性率为 30%。其他所有息肉和正常结肠黏膜均为 EGFR 阴性。在 16 名额外患者的 95 个腺瘤中,EGFR 阳性与腺瘤大小≥1 厘米和绒毛特征之间存在显著相关性(均 P<0.001)。高级别腺瘤中 EGFR 表达的几率是非高级别腺瘤的 17.3 倍(P<0.001)。
这些发现表明,EGFR 过度表达与结直肠高级别腺瘤有关。需要进一步进行更大规模的研究来探索 EGFR 表达作为腺瘤进展的生物标志物。